Hence, in some individuals with high genetic risk of T1D and β cell autoimmunity, a dysregulation of the PD-1/PD-L1 inhibitory pathway could be an additional mechanism leading to T1D. This evidence concerns the gene CD274 and type 1 diabetes mellitus.